Neurocrine Biosciences
NBIX
#1374
Rank
A$23.27 B
Marketcap
A$233.43
Share price
-0.33%
Change (1 day)
15.70%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company